Clinuvel Pharmaceuticals Limited (CLVLY) Q2 2025 Earnings Call Transcript

2025-02-28 18:17:06 ET

Clinuvel Pharmaceuticals Limited (CLVLY)

Q2 2025 Results Conference Call

February 27, 2025 02:00 AM ET

Company Participants

Stella Mariss - Monsoon Communications

Malcolm Bull - Head of IR

Peter Vaughan - Company Secretary and CFO

Lachlan Hay - Chief Operations Officer

Philippe Wolgen - Chief Executive Officer

Presentation

Stella Mariss

Hello, everyone. Thank you for joining CLINUVEL's Investor webinar today. I am Stella Mariss of Monsoon Communications. In today's webinar, CLINUVEL will share their half year results and operational highlights for the 6 months ended on 31st December 2024. Many have asked questions as you registered for the webinar, which may still be tabled during the session through the Q&A function.

I will now hand over to Malcolm Bull, Head of Investor Relations, and Australian Operations to conduct the proceedings.

Malcolm Bull

Thank you, Stella, and we do appreciate Monsoon Communications ongoing assistance in these presentations and welcome to the over 200 participants to the webinar. Joining me today is Peter Vaughan, Chief Financial Controller; and Lachlan Hay, our Chief Operations Officer.

Before we discuss financial results and operational highlights, as Stella said, for the half year 31 December 2024, just a few formalities. First, our forward-looking statement. I don't expect you to read all this, but many of you will be familiar with this type of statement, and that is -- there is a number of risks that can materialize that can impact upon the plans of the company. And you should take those into account in your ongoing assessment of CLINUVEL....

Read the full article on Seeking Alpha

For further details see: